Loading...
News Article

Breast screening breakthrough to end unnecessary biopsies

News

Harnessing photonics, European scientists have created a new mammographic imaging system that determines benign or malignant breast lesions - spelling an end for unnecessary biopsies and anguish for millions of women.

Scientists from the Horizon2020 project SOLUS have developed a non-invasive, multi-modal, imaging system that uses ultrasound and light technologies to easily differentiate between benign or malignant lesions – without having to perform a biopsy.

Similar to a pregnancy ultrasound appointment, a clinician scans the breast with a handheld ‘smart optode’ pen probe that combines light and sound to collate blood parameters and tissue constituents.

Using a technique called ‘diffuse optical imaging’ – a method that has provided breakthroughs in neuroscience, wound monitoring, and cancer detection – scientists can monitor changes in concentrations of oxygenated and deoxygenated haemoglobin, collagen, lipids and water present in a suspected tumour against a pre-programmed set of results.

While mammography is accurate in detecting breast lesions, many women encounter false positive results – a positive detection of a lump but with no malignant cancer present. Clinicians, however, do not necessarily know whether a lesion is cancerous or harmless and have to resort to invasive procedures, such as biopsies, to make an accurate diagnosis.

According to a recent study, false-positive breast biopsies cost more than €1.85 billion ($2 billion) per year in the United States alone.

While You Wait

Able to provide a malignant or benign diagnosis, the SOLUS scanner reads a number of different parameters to create a thorough characterization of tissue. Gathering the total blood volume and oxygenation, collagen, water and lipid content, together with stiffness and morphologic information, the system produces an accurate, while-you-wait diagnosis.

Aiming for 95% sensitivity and 90% specificity, the project has combined commercial ultrasound imaging and elastography with novel diffuse optical imaging approaches.

The scientists behind the ‘SOLUS’ project are confident their new system will revolutionise breast cancer diagnosis. Professor Paola Taroni from Politecnico di Milano, Italy, said: “Women may have to wait days or weeks for a malignant or benign result to come back, which causes distress, as well as great discomfort from an invasive biopsy.

“Astonishingly, millions of unnecessary biopsies are currently carried out across the world at a cost of millions of Euros in Europe, and potentially billions worldwide.”

“Having undergone extensive laboratory trials, the SOLUS team plan to validate the system in real clinical settings at the end of this year and through into 2021,” Professor Taroni said.

Diffuse Optics

With ‘diffuse optical imaging’ the system uses light as an investigative tool to look beneath the surface of the skin, without making an incision.

Harnessing photonics and acoustics, this new system gathers diagnostic information from the composition of tissue and blood by sending pulses of infrared light and ultrasound a few centimetres into the breast tissue.

A clinician can then determine whether a lump is benign or malignant given that cancerous tissue is characterized by high haemoglobin and water content, and low lipid content.

“We have been applying diffuse optics to different aspects of breast cancer (lesion discrimination and an estimate of cancer risk) for 20 years now. Our team developed a multi-wavelength time-domain optical mammography which was used in clinical studies on more than 400 patients.

“Now an upgraded version has just entered clinics for the monitoring of neoadjuvant chemotherapy of breast cancer. Furthermore, our group performed a lot of work on other diagnostic applications, such as functional brain imaging and muscle oximetry,” said Professor Taroni.

Peter Gordebeke, Research Manager from the European Institute for Biomedical Imaging Research said: “While SOLUS is developing biomedical imaging technologies to improve the diagnosis of breast cancer, we are making good use of diffuse optics for breast cancer and other medical diagnostics applications.

“SOLUS has created a user-friendly, non-invasive, low-cost, multi-modal imaging system for high-specificity diagnosis of breast cancer.”

“While our multi-modal imaging system can save millions of Euros by reducing the number of unnecessary biopsies, helping women across the world avoid these needless, painful procedures is priceless,” Gordebeke said.

SOLUS is supported by the European Commission in the framework of the EU Horizon 2020 ICT programme with a grant of € 3.8 million under the Photonics Public Private Partnership.

The project is coordinated by Politecnico di Milano and includes nine partners from European countries, including CEA-LETI, Commissariat à l'Energie Atomique et aux Energies Alternatives in Grenoble, Supersonic Imagine in Aix-en-Provence, Vermon in Tours, (France); University College London, (United Kingdom); Micro Photon Devices in Bolzano, San Raffaele Hospital in Milan, (Italy); The European Institute for Biomedical Imaging Research (EIBIR) in Vienna, (Austria); iC-Haus in Bodenheim, (Germany).

Quintessent appoints Bob Nunn chief operating officer
PI to demonstrate new PIC alignment system at Photonics West
Drut launches 2500 product series with CPO for AI datacentres
III-V Epi advocates GaAs for new lasers
Marvell announces new CPO architecture for custom AI accelerators
Printing high-speed modulators on SOI
Photon IP raises €4.75m for advanced PICs
ANELLO Photonics launches Maritime Inertial Navigation System
Aeluma joins AIM Photonics as full industry member
Imec makes breakthrough with GaAs lasers on silicon
POET acquires Super Photonics Xiamen
Voyant Photonics launches affordable Carbon LiDAR
Penn State makes breakthrough in photonic switching
New nanocrystals could lead to more efficient optical computing
QCi awarded NASA contract to apply Dirac-3 photonic optimisation solver
The Netherlands launches ChipNL Competence Centre
TOPTICA to create chip-integrated lasers for quantum PIC project
NSF selects six pilot projects for National Quantum Virtual Laboratory
SiLC Technologies launches Eyeonic Trace Laser Line Scanner
Southwest Advanced Prototyping Hub awarded $21.3 million CHIPS Act funding
Cambridge Graphene Centre and CORNERSTONE to participate in PIXEurope
Cost-effective lasers for extended SWIR applications
IBM unveils co-packaged optics technology for AI and datacentres
QCi announces $50 million concurrent stock offerings
CHIPS Act funding to be awarded to Coherent, Skywater, and X-Fab
ERC consolidator grant awarded for optoacoustic neural network project
Imec demonstrates InP chiplet integration on 300 mm RF silicon interposer
Ayar Labs raises $155 million for optical I/O
Celestial AI awarded 2024 Start-up to Watch by Global Semiconductor Alliance
Researchers develop “last missing piece” of silicon photonics
Quantum sensors for controlling prosthetics
UPVfab to participate in European Commission photonic chips project

×
Search the news archive

To close this popup you can press escape or click the close icon.
Logo
x
Logo
×
Register - Step 1

You may choose to subscribe to the PIC Magazine, the PIC Newsletter, or both. You may also request additional information if required, before submitting your application.


Please subscribe me to:

 

You chose the industry type of "Other"

Please enter the industry that you work in:
Please enter the industry that you work in: